Form 4: Guardant Health CEO Reports Stock Transaction
Insider Transaction (Form 4)
Helmy Eltoukhy, Co-Chief Executive Officer and a Director of Guardant Health, Inc., reported multiple transactions in common stock on August 26, 2026.
Summary
- Other acquisition/disposition: disposed of 25,000 Common Stock on August 26, 2026; holds 1,970,934 after (Indirect).
- Other acquisition/disposition: acquired 25,000 Common Stock on August 26, 2026; holds 60,000 after (Indirect).
- Bona fide gift: disposed of 30,000 Common Stock on August 26, 2026; holds 1,940,934 after (Indirect).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Helmy Eltoukhy — Director, Officer (Co-Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-26 | Other acquisition/disposition | Common Stock | 25,000 | — | — | 1,970,934 |
| 2026-08-26 | Other acquisition/disposition | Common Stock | 25,000 | — | — | 60,000 |
| 2026-08-26 | Bona fide gift | Common Stock | 30,000 | — | — | 1,940,934 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-26 | Other acquisition/disposition (25,000 shares) |
| 2026-08-26 | Other acquisition/disposition (25,000 shares) |
| 2026-08-26 | Bona fide gift (30,000 shares) |
Keywords
insider transaction, Form 4, GH, Guardant Health, Inc., neutral, Helmy Eltoukhy
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.